Lazard Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-6,218
Closed -$27K – 2313
2022
Q2
$27K Buy
+6,218
New +$44.9K ﹤0.01% 2039

Other funds holding SRTA

Lazard Asset Management's SRTA Position: Q3 2022 in Review

Lazard Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q3 2022, closing a stake of 6,218 shares — an estimated $27K sold.

Lazard Asset Management first reported a position in SRTA in Q2 2022 and held it in 1 quarter. The position peaked at $27K in Q2 2022. 99 funds tracked by Wall St. Rank hold SRTA as of Q3 2022.

  • Lazard Asset Management reported no remaining Strata Critical Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Lazard Asset Management sold 6,218 Strata Critical Medical Inc shares in Q3 2022, an estimated $27K.
  • Lazard Asset Management first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 1 quarter.
  • Lazard Asset Management's Strata Critical Medical Inc position peaked at $27K in Q2 2022.
  • 99 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2022.

Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.